Can physical activity predict treatment success in rheumatoid arthritis?
Part of Bones, joints & muscles, Brain & nervous system, Immune system & allergy, Skin clinical trials.
This study tests if measuring your physical activity over a short time can help predict how well a new biologic medication will work for your rheumatoid arthritis. The goal is to find a simple way to see if the treatment is helping.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You have rheumatoid arthritis
- You are about to start treatment with a biologic drug
- You can read and understand Danish
- You are not pregnant
- You don't need help walking (like a cane or walker)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether exercise training can affect gene activity (lncRNA) in rheumatoid arthritis patients with lung involvement. It may show how exercise helps manage the disease.
This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.
This study tests if a home-based exercise program, combined with anti-inflammatory strategies, can help people newly diagnosed with rheumatoid arthritis manage their symptoms and improve health. It's a remote program, so you can participate from home.
This study tests if a digital app called RheumaBuddy4.1 can help manage rheumatoid arthritis symptoms. You would use the app at home and report how you feel.
This study looks at how muscles use oxygen in people with rheumatoid arthritis. You will do some exercise tests to measure your muscle oxygen levels, which may help doctors understand how the disease affects your muscles.
This study looks at whether a blood test can predict how well people with rheumatoid arthritis will respond to a type of medication called anti-TNF. If successful, it could help doctors choose the right treatment earlier.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.